Researchers revealed in a study that offers significant insights into the causes of human lymph node function decline with ageing and the effects on immune system performance.
Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines -- such as doxorubicin, frequently used against breast cancer -- kill cancer cells by damaging their DNA.
The reasons why human lymph nodes become less functional with age and the effects on the efficiency of our immune system are the subject of a recent study conducted by researchers at Uppsala University.
According to new research, mice with colorectal cancer who have tumours with high levels of ammonia have fewer T cells and are less responsive to immunotherapy. Ammonia, which is crucial for anti-tumor immunity, has been demonstrated to impede the proliferation and operation of T cells.
According to a new, phase 2 clinical trial led by Dana-Farber Cancer Institute doctors, a three-medicine combination that drove chronic lymphocytic leukaemia (CLL) patients into profound remissions in a clinical study is very beneficial in patients with high-risk variants of the disease.
The number of people suffering from Anaplastic large-cell lymphoma (ALCL), a rare disease, has recently increased and this spike in numbers may be linked to the expanding popularity of textured breast implants.
Karolinska Institutet researchers have demonstrated that B lymphocytes, on which the efficient operation of the immune system depends, can occasionally cause more harm than good since their numbers sharply increase following intestinal trauma, impeding the healing process.
Anaplastic large-cell lymphoma (ALCL), a rare malignancy, has increased in frequency during the past several years, presumably as a result of the rising popularity of textured breast implants.
Wasteosomes, structures that act as storage facilities for waste products from the brain, are used to demonstrate the malfunction of the glymphatic system, a recently identified system that is a crucial brain-cleaning mechanism.
Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small set of patients with the autoimmune disease lupus. Penn Medicine C
A form of blood cancer known as mantle cell lymphoma is critically dependent on a protein that coordinates gene expression, such that blocking its activity with an experimental drug dramatically slows the growth of this lymphoma in preclinical tests, according to a study from Weill Cornell M
Washington [US], October 15 (ANI): Cancer cells use an unusual mechanism to migrate into new tissue and form metastases there. The same process probably also keeps some immune cells on their toes. According to the study, certain structures, the centrioles, increase in number. This makes it e